Obstetrics and Gynecology
Dr. Larry Herman, DMSc, MPA, PA-C, DFAAPA
Preeclampsia is a public health issue that involves early intervention among pregnant individuals. Pregnant patients should be adequately assessed for moderate to high risk for preeclampsia and begin prophylactic therapy with low-dose aspirin (LDA, 81 mg daily). This article discusses the most common pregnant individuals at risk for preeclampsia. It also reviews how aggressive identification of these individuals in early pregnancy coupled with prophylactic therapy aids in reducing complications such as preeclampsia during the third trimester and antepartum care.
Keywords: Preeclampsia, Pregnancy, Aspirin, Prevention
Finklea KN. Identifying Patients at Moderate to High Risk for Preeclampsia and Implementing Aspirin Therapy to Reduce Rates of Preeclampsia. Lynchburg Journal of Medical Science. 2022; 4(2).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.